Dade Behring推出D二聚体检测诊断血栓栓塞

 
Stratus CS急性护理D-二聚体检测方法，设计用于帮助诊断深静脉血栓症(DVT)及相关疾病。这种检测方法已经获得美国食品药品管理局的许可，可以用于帮助诊断DVT、静脉血栓症(VTE)和肺栓塞(PE)。

患上DVT，在腿、骨盆、或者上肢深静脉就会形成血凝块，导致部分或者完全的循环阻塞。临床症状不同，但是在50%的患者中，很少或者没有症状。早期诊断和治疗十分重要。PE发生在血凝块脱落或者发生栓塞，脱落至肺脏或者肺动脉。在美国PE每年导致的死亡比乳腺癌、公路死亡或者AIDS还要多。VTE是一种发生在静脉的栓塞。

“使用D-二聚体检测来诊断VTE、DVT或者PE，为世界范围内的实验室提供了另外一项重要方法，”Jim Reid-Anderson说，他是Dade Behring公司主席、总裁兼首席执行官，正是该公司研发了这种检测方法。“获得FDA的许可，扩大了这种检测方法的应用范围，这对Dade Behring公司十分重要，因为为临床医生提供了一种重要工具，同时使用预备几率评估，就可以进行静脉血栓症的诊断辅助工具(DVT or PE)。”

D-dimer Assay for Thromboembolism
 
The Stratus CS Acute Care D-dimer assay is designed to help diagnose deep vein thrombosis (DVT) and related conditions. The assay has been cleared by the U.S. Food and Drug Administration (FDA) for use as an aid to the diagnosis of DVT, venous thromboembolism (VTE) and pulmonary embolism (PE).

With DVT, a blood clot forms in the deep veins of the legs, pelvis, or upper extremities, leading to either partially or completely blocked circulation. Symptoms may vary, but in as many as 50% of patients, few or no symptoms are seen. Early diagnosis and treatment are essential. PE occurs when a clot breaks loose or embolizes and travels to the lungs or pulmonary artery. PE causes more U.S. deaths annually than breast cancer, highway fatalities, or AIDS. VTE is thromboembolism that occurs in the veins.

“The ability to use the D-dimer test as an aid in the diagnosis of VTE, DVT, or PE provides another significant offering to hospital laboratories worldwide,” said Jim Reid-Anderson, chairman, president, and CEO of Dade Behring, which developed the test. “Receiving FDA clearance for the expanded use for this assay is extremely important to Dade Behring because it provides another important tool for physicians to utilize, along with pretest probability assessment, as an aid in the diagnosis of venous thromboembolism (DVT or PE).”